Biphasic effects of propranolol on tumour growth in B16F10 melanoma‐bearing mice

BACKGROUND AND PURPOSE: Propranolol is a vasoactive drug that shows antiangiogenic and antitumour activities in melanoma. However, it is unknown whether these activities are dose‐dependent and whether there is a relationship between systemic vascular effects of propranolol and anti‐melanoma activity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Maccari, Sonia, Buoncervello, Maria, Rampin, Andrea, Spada, Massimo, Macchia, Daniele, Giordani, Luciana, Stati, Tonino, Bearzi, Claudia, Catalano, Liviana, Rizzi, Roberto, Gabriele, Lucia, Marano, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5192956/
https://ncbi.nlm.nih.gov/pubmed/27792834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13662
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados